Table 1 Prevalence rates (%) and relative risks (RR) of HBsAg, HBcAb and HCV in hospitalized patients over the 1992–1996 time period by sex.

HBsAg

Heraklion

1992–4

2979

6,11

3553

2,81

4,32

2,17

^**

1995

1874

4,59

2534

2,57

3,43

1,79

^**

1996

1741

5,11

2710

3,25

3,98

1,57

^*

Overall

5,41

2,88

3,96

1,88

^**

Hania

1992

1502

3,13

1381

1,38

2,29

2,27

^*

1993

3016

2,39

2634

1,29

1,88

1,85

^*

1994

2782

3,16

2497

1,88

2,56

1,68

^*

1995

2156

2,41

1710

2,11

2,28

1,15

1996

1847

3,14

1760

2,10

2,63

1,49

Overall

2,80

1,73

2,30

1,62

^**

Rethymnon

1992

697

3,01

915

0,77

1,74

3,94

^*

1993

1369

1,39

912

0,66

1,10

2,11

1994

871

2,41

1154

1,21

1,73

1,99

1995

970

1,75

1115

0,81

1,25

2,17

1996

975

2,15

1247

1,12

1,58

1,92

Overall

2,03

0,94

1,45

2,17

^**

HBcAbⁿ

Heraklion

1992–4

2979

25.26

3553

17.69

21,14

1995

1874

24,76

2534

14,56

18,90

1,70

^**

1996

1741

26,77

2710

15,09

19,66

1,77

^**

Overall

25.51

15.99

20,07

1,73

^**

Hania

1992

843

23,61

587

22,66

23,22

1,04

1993

919

22,63

712

24,16

23,30

0,94

1994

590

23,39

710

11,41

16,85

2,05

^**

1995

816

34,80

424

28,30

32,58

1,23

1996

529

23,06

460

13,48

18,60

1,71

^**

Overall

25,72

19,63

23,05

1,31

^**

HCV

Heraklion

1992–4

3319

8,44

3959

7,35

7,85

1,15

1995

1817

6,27

2361

5,12

5,62

1,22

1996

1713

6,25

2656

4,63

5,26

1,35

Overall

7,31

5,96

6,54

6,55

^**

Hania

1992

739

1,49

903

0,78

1,10

1,92

1993

1323

2,34

901

2,11

2,25

1,11

1994

1928

4,15

1540

3,05

3,66

1,36

1995

1542

1,82

1075

2,23

1,99

0,81

1996

1794

2,79

1215

1,15

2,13

2,42

^**

Overall

2,73

1,97

2,39

1,39

^*

Rethymnon

1992

237

16,03

250

10,00

12,94

1,60

1993

763

3,93

452

7,52

5,27

0,52

1994

576

4,34

499

6,21

5,21

0,70

1995

573

2,27

618

3,72

3,02

0,61

1996

595

3,87

807

4,34

4,14

0,89

Overall

4,70

5,64

5,15

0,83